The ability of IL-6 to inhibit tumor cell growth has been suggested, as IL-6 functions synchronously with IL-1 and TNF-α in order to support anti-tumor immunity [53] and has been shown to regulate the ability of AMs in lung cancer to be stimulated by IFN-γ and LPS[54]. This evidence concerns the gene IFNG and lung carcinoma.